Heikki Seikkula

- Docent,
Department of Clinical Medicine (Faculty of Medicine)

hearse@utu.fi

Kiveksen kasvaimet (2024) Kirurgia Boström, Peter; Hemminki, Otto; Seikkula, Heikki
Virtsaumpi ja katetrointi (2024) Kirurgia Kilpeläinen, Tuomas; Seikkula, Heikki
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)
- Cancers
Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko
Vasectomy and the risk of prostate cancer in a Finnish nationwide population-based cohort (2020)
- Cancer Epidemiology
Seikkula H, Kaipia A, Hirvonen E, Rantanen M, Pitkäniemi J, Malila N, Boström PJ
New prostate cancer grade grouping system predicts survival after radical prostatectomy (2018)
- Human Pathology
Andrew Erickson, Kevin Sandeman, Kanerva Lahdensuo, Stig Nordling, Markku Kallajoki, Heikki Seikkula, Anna Bützow, Hanna Vasarainen, Peter J. Boström, Pekka Taimen, Antti Rannikko, Tuomas Mirtti
The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland (2018)
- International Journal of Cancer
Seikkula HA, Kaipia AJ, Ryynänen H, Seppä K, Pitkäniemi JM, Malila NK, Boström PJ
Comparison of functional outcome after extended versus super-extended pelvic lymph node dissection during radical prostatectomy in high-risk localized prostate cancer (2017)
- Frontiers in Oncology
Heikki Seikkula, Pieter Janssen, Manuela Tutolo, Lorenzo Tosco, Antonino Battaglia, Lisa Moris, Thomas Van den Broeck, Maarten Albersen, Gert De Meerleer, Hendrik Van Poppel, Wouter Everaerts, Steven Joniau
Stage-specific mortality and survival trends of prostate cancer patients in Finland before and after introduction of PSA (2017)
- Acta Oncologica
Seikkula HA, Kaipia AJ, Rantanen ME, Pitkäniemi JM, Malila NK, Boström PJ
Studies on prostate-specific antigen and prostate cancer epidemiology (2017) Seikkula Heikki
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy (2016)
- International Journal of Cancer
Yu L, Toriseva M, Tuomala M, Seikkula H, Elo T, Tuomela J, Kallajoki M, Mirtti T, Taimen P, Bostrom PJ, Alanen K, Nurmi M, Nees M, Harkonen P
Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomy (2016)
- Scientific Reports
Laajala TD, Seikkula H, Sadat FS, Mirtti T, Boström PJ, Elo LL.
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy. (2016)
- Modern Pathology
Lahdensuo K, Erickson A, Saarinen I, Seikkula H, Lundin J, Lundin M, Nordling S, Bützow A, Vasarainen H, Boström PJ, Taimen P, Rannikko A, Mirtti T.
Differential predictive roles of A- and B-type nuclear lamins in prostate cancer progression (2015)
- PLoS ONE
Saarinen I, Mirtti T, Seikkula H, Boström PJ, Taimen P
PSA ja eturauhassyövän verinäytediagnostiikka (2015)
- Duodecim
Seikkula H, Pettersson K, Boström PJ
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomy (2014)
- Urologic Oncology: Seminars and Original Investigations
Seikkula H, Syvänen K, Kurki S, Mirtti T, Taimen P, Laato M, Boström P